Summit Trail Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Buy |
+6,500
| New | +$893K | 0.02% | 520 |
|
|
2024
Q4 | – | Sell |
-10,401
| Closed | -$1.89M | – | 597 |
|
|
2024
Q3 | $1.89M | Buy |
+10,401
| New | +$1.89M | 0.05% | 166 |
|
|
2023
Q4 | – | Sell |
-4,555
| Closed | -$528K | – | 579 |
|
|
2023
Q3 | $528K | Hold |
4,555
| – | – | 0.02% | 258 |
|
|
2023
Q2 | $535K | Buy |
+4,555
| New | +$535K | 0.02% | 253 |
|